Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Walmart Stores Inc (WMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Walmart Stores Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Walmart Stores Inc trades at $116.95 (market cap $890.80B). The key difference: Walmart Stores Inc is far larger — about 100.4× Kymera Therapeutics Inc. Common Stock's market cap, and Walmart Stores Inc pays a 0.88% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Walmart Stores Inc for 101 Days on average.
| KYMR | WMT | |
|---|---|---|
Market Cap | $8.87B | $890.80B |
Volume | 779,107 | 17,493,315 |
Sector | Health | Consumer Staples |
52-Week High | $127.31 | $134.20 |
52-Week Low | $55.80 | $100.61 |
Typical Hold Time | 0 Days | 101 Days |
Enterprise Value | $8.26B | $953.03B |
Dividend Yield | — | 0.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Walmart (WMT) trades at $113.08, up 1.55% today, with a bullish technical signal from moving averages and strong fundamental performance. Revenue grew to $680.99B in 2025, with net income reaching $19.44B, and the company has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion in AI capabilities, e-commerce growth exceeding 50%, and a new Medicare Advantage partnership, signaling strategic initiatives to bolster market share.
The outlook for WMT is positive, supported by robust earnings growth, analyst consensus favoring buys (71%), and a price target of $128.84 implying ~14% upside. Key risks include elevated valuation multiples (P/E 40.68) and rising operational costs, but the company's scale and digital investments provide a competitive edge. Investors should weigh growth prospects against cost pressures and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Walmart Stores Inc
Walmart Inc. operates discount stores, supercenters, and neighborhood markets. The Company offers merchandise such as apparel, house wares, small appliances, electronics, musical instruments, books, home improvement, shoes, jewelry, toddler, games, household essentials, pets, pharmaceutical products, party supplies, and automotive tools. Walmart serves customers worldwide.
Read more on WMT →
